On July 21, 2025, Nicholas Holowko from UBS set a price target of $64 for Comerica (NYSE:CMA). At that time, the stock was trading at $64.57, slightly above the target by about 0.88%. UBS maintained a neutral rating on Comerica, as highlighted by StreetInsider. This neutral stance comes despite Comerica's strong financial performance in the second quarter.
Comerica reported impressive earnings for the second quarter, surpassing analyst expectations. The company achieved earnings of $1.42 per share, exceeding the consensus estimate of $1.26 per share. Additionally, Comerica's quarterly sales reached $849 million, beating the expected $842.389 million. Following this positive earnings announcement, Comerica's shares rose by 4.7%, closing at $65.32 on Friday.
In response to the strong performance, several analysts adjusted their forecasts for Comerica. Keefe, Bruyette & Woods analyst Christopher Mcgratty maintained an Outperform rating for the company and increased the price target from $69 to $73. Similarly, Stephens & Co. analyst Terry McEvoy maintained an Equal-Weight rating and raised the price target from $61 to $68. These adjustments reflect a positive outlook on Comerica's future performance.
The current stock price of CMA is $64.70, reflecting a decrease of approximately 0.96% or $0.63. Today, the stock has traded between a low of $64.39 and a high of $65.49. Over the past year, CMA has reached a high of $73.45 and a low of $48.12. The company's market capitalization stands at approximately $8.5 billion. Today's trading volume for CMA is 1,302,402 shares on the NYSE.
